NCT00651222 Influence of Hormone Therapy on Heart Attack Incidence in Men Undergoing Prostate Brachytherapy Status COMPLETED Phase N/A
NCT00644488 A Phase I Study of BMS-641988 in Japanese Patients With Castration Resistant Prostate Cancer Status COMPLETED Phase PHASE1
NCT00643994 CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution Status COMPLETED Phase NA
NCT00643617 CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry Status COMPLETED Phase NA
NCT00642018 A Study of an Experimental Chemotherapy Combination to Treat Hormone Refractory Prostate Cancer Status COMPLETED Phase PHASE2
NCT00638378 Study of Ruxolitinib (INCB018424) Administered Orally to Patients With Androgen Independent Metastatic Prostate Cancer Status TERMINATED Phase PHASE2
NCT00637208 Sclerotherapy of Internal Spermatic Veins in Patients With Varicocele and Localized Prostate Cancer Status COMPLETED Phase NA
NCT00636558 Coxsackie Virus A21 Administered Intravenously (IV) for Solid Tumour Cancers (PSX-X04) Status COMPLETED Phase PHASE1
NCT00635856 Open Label Trial to Assess Iressa in Prostate Cancer Patients Status COMPLETED Phase PHASE2
NCT00635167 Contrast Enhanced Transrectal Ultrasonography (TRUS) to Assess Prostatic Vascularity After Radiotherapy (XRT) Status TERMINATED Phase NA
NCT00634582 Paricalcitol in Treating Patients With Advanced Prostate Cancer and Bone Metastases Status TERMINATED Phase PHASE2
NCT00633087 A Phase I/II Trial of 2-Deoxyglucose (2DG) for the Treatment of Advanced Cancer and Hormone Refractory Prostate Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00632138 Pelvic Floor Muscle Training and Biofeedback or Standard Therapy in Men Who Have Undergone Radical Prostatectomy or Transurethral Resection of the Prostate Status COMPLETED Phase PHASE3
NCT00631527 Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate Cancer Status COMPLETED Phase PHASE1
NCT00630799 Efficacy and Safety Study of a New Leuprolide Acetate 17 mg Depot to Treat Prostate Cancer Patients Status TERMINATED Phase PHASE3
NCT00630344 RAD001 and Bicalutamide for Androgen Independent Prostate Cancer Status COMPLETED Phase PHASE2
NCT00629330 Dissemination of Prostate Cancer Screening to PCP's in African American Communities Status TERMINATED Phase PHASE4